![A 59-year-old man with a previous history of oral cavity cancer treated with surgery underwent an ^18^F-FDG PET/CT for restaging purpose. PET/CT was positive, showing the presence of local relapse at the right side of the tongue and several laterocervical lymph nodes (**A** and **B**). Moreover, FDG-positive plural diffuse interstitial alterations with ground-glass opacities (GGOs) appearance were registered with SUV~max~ of 13.8 (**C** and **D**). Concomitant mediastinal nodes with increased FDG uptake were present (**E**). A subsequent chest radiographs confirmed a diffuse interstitial pneumonia; reverse transcriptase polymerase chain reaction (RT-PCR) was positive, and the patient was hospitalized for specific therapy.](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003150-g001){#FU1}

![A 47-year-old woman affected by an advanced stage anaplastic large-cell lymphoma relapsed after 2 chemotherapy regimen lines and was hospitalized for starting new chemotherapy cycle. Before starting, she did a nasopharyngeal swap with RT-PCR positive for COVID-19. ^18^F-FDG PET/CT confirmed the metabolic progression of disease with nodal, muscular, and skeletal hypermetabolic localizations (**A**). A moderate FDG uptake (SUV~max~, 5.6) was showed in small GGOs, especially in the left inferior lobe (**B**--**D**). A subsequent chest CT demonstrated a progression of interstitial pneumonia with massive lung involvement (**E--G**).](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003150-g002){#FU2}

![An asymptomatic 77-year-old man with non--Hodgkin lymphoma treated previously with one line of chemotherapy underwent an ^18^F-FDG PET/CT showing increased FDG uptake to several abdominal nodes consistent of relapse (**A--C**) and the presence of bilateral pleural thickening and FDG-avid GGOs with SUV~max~ of 10.2 (**D--G**). After the appearance of dyspnea and breathing difficulty, he went to the emergency unit and was hospitalized and started treatment with hydroxychloroquine.](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003150-g003){#FU3}

![A 62-year-old man affected by follicular lymphoma underwent PET/CT scan for evaluating treatment response after 6 cycles of chemotherapy, and PET/CT showed a partial metabolic response with persistence of increased FDG uptake to an inguinal node (**A--D**) and the appearance of several bilateral lung consolidative and FDG-avid nodular areas, especially in the superior lobes with SUV~max~ of 9 (**E--G**). Being the pattern atypical for COVID-19, the patient started new chemotherapy regimen, but after the early onset of cough and dyspnea, RT-PCR test was done with positive finding for COVID-19. Chest radiographs and CT is the preferred examinations for screening, diagnosis, and monitoring of COVID-19 pneumonia.^[@bib1]--[@bib3]^ In this setting, the role of ^18^F-FDG PET/CT is still unclear with only few cases present.^[@bib4]--[@bib10]^ ^18^F-FDG PET/CT is a noninvasive tool with a significant role in evaluating several phlogistic and infectious pulmonary diseases, such as sarcoidosis and tuberculosis.^[@bib11]^ However, usually lesions presenting as GGOs are unlikely to have FDG uptake.^[@bib12]^ In agreement with previous articles,^[@bib6]--[@bib8]^ our patients were characterized by the presence of bilateral peripheral consolidative areas and/or GGOs. All had increased FDG uptake higher than blood pool activity. COVID-19 do not seem to be associated with lymph node involvement; however, Qin et al^[@bib6]^ reported an increased nodal FDG uptake in 3 of 4 cases. Of course ^18^F-FDG PET/CT is not routinely recommended for pulmonary lung inflammatory diseases and not indicated in an emergency setting, but our findings underline that COVID-19 pneumonia are characterized by high ^18^F-FDG uptake in most cases despite GGOs appearance.](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003150-g004){#FU4}
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